In a recent speech to the IFT International Nanoscience Conference, Dr. Annette McCarthy of the FDA, is quoted as saying "We believe that the regulatory authority is sufficient to address nanotechnology. But there are further questions we need to address". J. Clarence Davies, currently with the Woodrow Wilson International Center  project on Emerging Nanotechnologies, might … Continue Reading